Puja Pathuri, Ph.D. - Publications

Affiliations: 
2007 University of California, Irvine, Irvine, CA 
Area:
Biochemistry

5/15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Tisi D, Chiarparin E, Tamanini E, Pathuri P, Coyle JE, Hold A, Holding FP, Martin AC, Rich SJ, Berdini V, Yon J, Acklam P, Burke R, Drouin L, Harmer JE, et al. Structure of the Epigenetic Oncogene MMSET & Inhibition by N-Alkyl Sinefungin Derivatives. Acs Chemical Biology. PMID 27571355 DOI: 10.1021/Acschembio.6B00308  0.329
2009 Pathuri P, Nguyen ET, Ozorowski G, Svärd SG, Luecke H. Apo and calcium-bound crystal structures of cytoskeletal protein alpha-14 giardin (annexin E1) from the intestinal protozoan parasite Giardia lamblia. Journal of Molecular Biology. 385: 1098-112. PMID 19046974 DOI: 10.1016/J.Jmb.2008.11.012  0.652
2008 Pathuri P, Vogeley L, Luecke H. Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form. Journal of Molecular Biology. 383: 62-77. PMID 18783790 DOI: 10.1016/J.Jmb.2008.04.076  0.499
2007 Pathuri P, Nguyen ET, Svärd SG, Luecke H. Apo and calcium-bound crystal structures of Alpha-11 giardin, an unusual annexin from Giardia lamblia. Journal of Molecular Biology. 368: 493-508. PMID 17355882 DOI: 10.1016/J.Jmb.2007.02.016  0.714
2006 Pathuri P, Nguyen ET, Luecke H. Expression, purification, crystallization and preliminary X-ray diffraction analysis of alpha-11 giardin from Giardia lamblia. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 62: 1108-12. PMID 17077490 DOI: 10.1107/S1744309106039650  0.675
Low-probability matches (unlikely to be authored by this person)
2012 Saalau-Bethell SM, Woodhead AJ, Chessari G, Carr MG, Coyle J, Graham B, Hiscock SD, Murray CW, Pathuri P, Rich SJ, Richardson CJ, Williams PA, Jhoti H. Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function. Nature Chemical Biology. 8: 920-5. PMID 23023261 DOI: 10.1038/nchembio.1081  0.266
2013 Pathuri P, Norton D, Willems H, Tisi D, Jhoti H. Structural Biology and Anticancer Drug Design Cancer Drug Design and Discovery: Second Edition. 121-141. DOI: 10.1016/B978-0-12-396521-9.00004-8  0.153
2011 Pathuri P, Chessari G, Carr MG, Congreve M, Coyle JE, Day PJ, Fazal L, Frederickson M, Graham B, Lewis J, McMenamin R, Murray CW, O'Brien AM, Patel S, Williams G, et al. Fragment-based drug discovery applied to heat shock protein 90 (HSP90) Acta Crystallographica Section a Foundations of Crystallography. 67: C303-C303. DOI: 10.1107/S0108767311092415  0.128
2012 Pathuri P, Saalau-Bethell SM, Woodhead AJ, Carr MG, Chessari G, Coyle J, Frederickson M, Graham B, Hamlett C, Hiscock SD, Holding FP, Jhoti H, McMenamin R, Murray CW, Reader M, et al. Discovery of novel allosteric inhibitors of HCV NS3/4a enzyme via structure-based drug design Acta Crystallographica Section a Foundations of Crystallography. 68: s27-s27. DOI: 10.1107/S0108767312099473  0.114
2013 Howard S, Amin N, Benowitz AB, Chiarparin E, Cui H, Deng X, Heightman TD, Holmes DJ, Hopkins A, Huang J, Jin Q, Kreatsoulas C, Martin AC, Massey F, McCloskey L, ... ... Pathuri P, et al. Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase. Acs Medicinal Chemistry Letters. 4: 1208-12. PMID 24900632 DOI: 10.1021/ml4003277  0.105
2021 Heightman TD, Berdini V, Bevan L, Buck IM, Carr MG, Courtin A, Coyle JE, Day JEH, East C, Fazal L, Griffiths-Jones CM, Howard S, Kucia-Tran J, Martins V, Muench S, ... ... Pathuri P, et al. Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2. Journal of Medicinal Chemistry. PMID 34387469 DOI: 10.1021/acs.jmedchem.1c00905  0.095
2015 Pathuri P, Saalau-Bethell SM, Woodhead AJ, Berdini V, Carr MG, Chessari G, Cleasby A, Congreve M, Coyle JE, Graham B, Hiscock SD, Lock V, Murray CW, O'Brien MA, Rich SJ, et al. Identification of novel allosteric inhibitors through fragment-based drug discovery and X-ray crystallography   Acta Crystallographica Section a Foundations and Advances. 71: s38-s38. DOI: 10.1107/S2053273315099398  0.081
2018 Heightman TD, Berdini V, Braithwaite H, Buck IM, Cassidy M, Castro J, Courtin A, Day JEH, East C, Fazal L, Graham B, Griffiths-Jones CM, Lyons JF, Martins V, Muench S, ... ... Pathuri P, et al. Fragment-based discovery of a potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2. Journal of Medicinal Chemistry. PMID 29775310 DOI: 10.1021/Acs.Jmedchem.8B00421  0.078
2024 Woodhead AJ, Erlanson DA, de Esch IJP, Holvey RS, Jahnke W, Pathuri P. Fragment-to-Lead Medicinal Chemistry Publications in 2022. Journal of Medicinal Chemistry. PMID 38289623 DOI: 10.1021/acs.jmedchem.3c02070  0.067
2012 Wilsher N, Saalau-Bethell S, Woodhead A, Millemaggi A, Graham B, Hamlett C, Murray C, Norton D, Rees D, Chiarparin E, Willems H, Lewis J, Fazal L, Carr M, Hodder M, ... ... Pathuri P, et al. 878 PRE-CLINICAL CHARACTERISATION OF A NOVEL DIRECT ACTING ANTIVIRAL AGENT WITH A NEW MODE OF ACTION Journal of Hepatology. 56: S342. DOI: 10.1016/S0168-8278(12)60890-3  0.043
Hide low-probability matches.